Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

The conclusion is that the increasing use of drugs for lifestyle reasons is a complex issue influenced by corporate profit, consumer behavior, and the medicalization of everyday life, with potential negative effects on personal well-being.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

The document concludes that cosmetic surgery is still mainly a practice for women and the gender gap in this field is expected to continue.

ADSC-CM treatment improved hair density and thickness in women with hair loss, safely and effectively.

The document concludes that accurate diagnosis of hair disorders is crucial and requires a range of diagnostic methods.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Nanocapsules can improve clobetasol delivery to hair follicles, reducing side effects.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Children with scalp fungal infections need proper diagnosis and treatment, usually with antifungal medications, and newer drugs may offer quicker recovery.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

PRP injections effectively treat hair loss, with positive results in both monthly and every three months treatments.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

The VQ-Dermato is a reliable French questionnaire for measuring quality of life in chronic skin disorder patients.

Some alternative treatments for hair loss might work, but more research is needed.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Skin diseases significantly lower the quality of life for patients in southern Brazil, especially for younger, single, and lower-income individuals.